Literature DB >> 34558602

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Maria Bäck, Athanase Benetos1, Alessandro Biffi2,3, José-Manuel Boavida4, Davide Capodanno, Bernard Cosyns, Carolyn Crawford, Constantinos H Davos, Ileana Desormais, Emanuele Di Angelantonio, Oscar H Franco, Sigrun Halvorsen, F D Richard Hobbs5, Monika Hollander, Ewa A Jankowska, Matthias Michal6, Simona Sacco7, Naveed Sattar, Lale Tokgozoglu8, Serena Tonstad, Konstantinos P Tsioufis9, Ineke van Dis10, Isabelle C van Gelder, Christoph Wanner11, Bryan Williams.   

Abstract

Entities:  

Keywords:  Guidelines; air pollution; blood pressure; climate change; diabetes; healthy lifestyle; lifetime benefit; lifetime risk; lipids; nutrition; personalized; population; prevention; psychosocial factors; risk estimation; risk management; shared decision-making; smoking; stepwise approach

Mesh：

Year:  2022        PMID： 34558602     DOI： 10.1093/eurjpc/zwab154

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN： 2047-4873            Impact factor:   7.804


× No keyword cloud information.
  27 in total

1.  Cardiovascular Risk Stratification and Appropriate Use of Statins in Patients with Chronic Kidney Disease According to Different Strategies.

Authors:  Leandro Barbagelata; Walter Masson; Emiliano Rossi; Martin Lee; Juan Lagoria; Manuel Vilas; Rodolfo Pizarro; Guillermo Rosa Diez
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-06-25

2.  A Reassessment of the Causal Effects of Dysglycemia on Atherosclerotic and Thrombotic Events.

Authors:  Jordi Merino
Journal:  Diabetes       Date:  2022-10-01       Impact factor: 9.337

3.  Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper.

Authors:  Pierre Sabouret; Gilles Lemesle; Anne Bellemain-Appaix; Pierre Aubry; Pier-Paolo Bocchino; Erik Rafflenbeul; Loïc Belle; Jim Nolan; Marco Bernardi; Giuseppe Biondi-Zoccai; Michael P Savage; Maciej Banach; Guillaume Cayla
Journal:  Arch Med Sci       Date:  2022-06-23       Impact factor: 3.707

4.  Proprotein convertase subtilisin/kexin type 9 inhibitor non responses in an adult with a history of coronary revascularization: A case report.

Authors:  Liu Yang; Yan-Yan Xiao; Liang Shao; Chang-Sheng Ouyang; Yao Hu; Bin Li; Li-Feng Lei; Hong Wang
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

5.  Whole-Blood Transcriptional Profiles Enable Early Prediction of the Presence of Coronary Atherosclerosis and High-Risk Plaque Features at Coronary CT Angiography.

Authors:  Daniele Andreini; Eleonora Melotti; Chiara Vavassori; Mattia Chiesa; Luca Piacentini; Edoardo Conte; Saima Mushtaq; Martina Manzoni; Eleonora Cipriani; Paolo M Ravagnani; Antonio L Bartorelli; Gualtiero I Colombo
Journal:  Biomedicines       Date:  2022-06-02

6.  Cholesterol and Hypertension Treatment Improve Coronary Risk Prediction but Not Time-Dependent Covariates or Competing Risks.

Authors:  Isaac Subirana; Anna Camps-Vilaró; Roberto Elosua; Jaume Marrugat; Helena Tizón-Marcos; Ivan Palomo; Irene R Dégano
Journal:  Clin Epidemiol       Date:  2022-10-11       Impact factor: 5.814

7.  Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis.

Authors:  Maximilian Brockmeyer; Georg Wolff; Yingfeng Lin; Claudio Parco; Athanasios Karathanos; Torben Krieger; Volker Schulze; Nadja Chernyak; Andrea Icks; Malte Kelm
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

8.  Early Detection of Cardiovascular Risk Factors and Definition of Psychosocial Profile in Women Through a Systematic Approach: The Monzino Women Heart Center's Experience.

Authors:  Sebastiano Gili; Mattia Giuliani; Giulia Santagostino Baldi; Giovanni Teruzzi; Gabriella Pravettoni; Piero Montorsi; Daniela Trabattoni
Journal:  Front Cardiovasc Med       Date:  2022-03-08

Review 9.  New Aspects in the Management of Hypertension in Patients with Chronic Kidney Disease not on Renal Replacement Therapy.

Authors:  Aikaterini Damianaki; Erietta Polychronopoulou; Gregoire Wuerzner; Michel Burnier
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-12-15

10.  Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.

Authors:  Julian Friebel; Eileen Moritz; Marco Witkowski; Kai Jakobs; Elisabeth Strässler; Andrea Dörner; Daniel Steffens; Marianna Puccini; Stella Lammel; Rainer Glauben; Franziska Nowak; Nicolle Kränkel; Arash Haghikia; Verena Moos; Heinz-Peter Schutheiss; Stephan B Felix; Ulf Landmesser; Bernhard H Rauch; Ursula Rauch
Journal:  Cells       Date:  2021-12-13       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.